CHOP researchers have found that CPR with rescue breathing leads to better neurological outcomes in pediatric cardiac arrest, highlighting a need for education.

Since March 2020, CHOP researchers have played a vital role in combatting the COVID-19 pandemic. Read highlights of their game-changing work.

CHOP researchers found that children with Fontan circulation are slightly shorter than their peers, but further studies are needed to determine whether this effect is long-lasting.

CHOP researchers authored an editorial in JAMA Pediatrics on the effects of the COVID-19 pandemic on youth mental health.

A collaborative team of researchers, including Dr. Stephan Grupp, recently presented preliminary data showing that a CRISPR-based gene-editing therapy for inherited blood disorders is safe and effective.

CHOP researchers have identified six biomarkers in the breath of children with COVID-19, laying the groundwork for a potential breathalyzer test.

CHOP researchers have developed a coating for endotracheal tubes that prevents the growth of harmful bacteria that cause inflammation and other complications.

CHOP researchers have identified two proteins that could be used for a potential vaccine against nontypeable Haemophilus influenzae, a bacterium that can lead to death in children and adults.

The landmark TODAY2 study found that those diagnosed with type 2 diabetes during childhood and adolescence have a high risk of developing serious health complications by early adulthood.

CHOP researchers have developed a “dimmer switch” system based on alternative RNA splicing that can control levels of proteins expressed from gene therapy vectors.